252.55
-1.90
(-0.75%)
As of 10:54:08 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
11,490,000
11,490,000
8,471,000
9,721,000
9,261,000
Investing Cash Flow
-1,046,000
-1,046,000
-26,204,000
-6,044,000
733,000
Financing Cash Flow
-9,415,000
-9,415,000
21,048,000
-4,037,000
-8,271,000
End Cash Position
11,973,000
11,973,000
10,944,000
7,629,000
7,989,000
Capital Expenditure
-1,096,000
-1,096,000
-1,112,000
-936,000
-880,000
Issuance of Debt
--
--
27,777,000
6,919,000
4,945,000
Repayment of Debt
-3,600,000
-3,600,000
-1,454,000
--
-4,150,000
Repurchase of Capital Stock
-200,000
-200,000
--
-6,360,000
-4,975,000
Free Cash Flow
10,394,000
10,394,000
7,359,000
8,785,000
8,381,000
12/31/2021 - 11/17/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BRM.DE Bristol-Myers Squibb Company
43.88
0.00%
6MK.DE Merck & Co., Inc.
67.50
-1.60%
C43.DE Cosmo Pharmaceuticals N.V.
52.50
0.00%
GIS.DE Gilead Sciences, Inc.
92.46
-1.03%
IDP.DE Biogen Inc.
102.35
-1.35%
4AB.DE AbbVie Inc.
151.20
-1.18%
SNW.DE Sanofi
89.51
-1.00%
GS71.DE GSK plc
15.45
-2.00%
ZEG.DE AstraZeneca PLC
117.60
-1.88%
LLY.DE Eli Lilly and Company
648.00
-1.47%